Subscribe to newsletters Sign in

Pharmaceutical company advocates for more accessible healthcare

By Frédérique De Simone | November 05 2019 10:06AM

Paula Keays

Photo: Cercle Canadien de Montréal

McKesson Canada President Paula Keays is appealing to the pharmaceutical and medical industry to improve accessibility to care and to unclog health care systems.

This article is reserved to PRO Level subscribers

Read the whole article….

PRO

$9.95 / month

Invest in your career and go PRO now!:

Each of its 6 annual issues offers you:

Exclusive headlines and daily scoops
Disciplinary decision news
On the move in the industry

Receive the Insurance Journal at your office or home:

6 issues/year
In-depth articles and studies related to the insurance industry
Insighful data to feed your analysis and convince your clients
Exclusive interviews with industry leaders

The most popular in Health

New federal price controls could hurt launch of new drugs

Digital health key to more affordable health services, says report

Family members and friends help those with mental illness

Headlines

Dwindling interest in classroom continuing education raises concerns

Insurers should rethink business models

CPA Canada provides tips to prevent fraud

Related to the same topic …

Flash

Insurers should rethink business models

Empire Life posts net income of $174 million for 2019

BCSC appoints new Vice-Chair

Agent suspended five years for benefits fraud

Supplementary health insurance

New technologies offer promise in the fight against fraud

CHES announces new life insurance affiliate

The Edge Benefits launches program for Alberta farmers

Digital health key to more affordable health services, says report

Drug insurance

CLHIA asks for strategies on expensive drugs and retirement plans

Pharmaceutical treatments lacking

Rare and orphan diseases: a challenge for individuals and society

Pharmacare plan for Canadians still a question mark

Group Insurance

Younger workers show strong interest in virtual healthcare

Sun Life makes $560 million buy-in group annuity deal with Rio Tinto subsidiary

Consolidation trend continues

Canada Life aims to eliminate plastic drug cards

Drug Insurance

Advocate sounds alarm about the future availability of new medicines in Canada

Investing in mental health yields significant returns

Biosimilars: British Columbia extends transition program

SSQ offers pharmacogenetic testing to group plan members

Life Insurance

Canadians support action to fight insurance fraud

Mackenzie launches new fund

Desjardins surplus earnings up 11.7 per cent in 2019

Seg fund sales decline

Medication

Health care markets poised for growth

Report on virtual health care released

Family members and friends help those with mental illness

Concern rises around smoking and vaping